# Risk: __Disease severity in re-infected patients__ (PBN__Risk_1913)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [comparative studies and data analysis technologies](../Technology/PBN__Technology_1311)

## Property: has_RiskSubject

* [re-infected patients](../Stakeholder/PBN__Stakeholder_1295)
* [researchers](../Stakeholder/PBN__Stakeholder_2)

## Property: has_RiskType

* [medical](../RiskType/PBN__RiskType_15)

## Property: has_RiskISO_Purpose

* [Health and care](../RiskISO/PBN__RiskISO_Impact_3)

## Property: has_RiskOwner

* [healthcare providers](../Stakeholder/PBN__Stakeholder_121)
* [researchers](../Stakeholder/PBN__Stakeholder_2)

## Property: has_RiskMitigation

* [Conduct comparative studies on disease severity between re-infected and initially infected patients.](../RiskMitigation/PBN__RiskMitigation_2515)

## Property: has_RiskName

Difficulty in assessing the impact of re-infections on disease severity.

## Property: has_RiskDescription

Unclear difference in disease severity between re-infected patients and patients with initial infection.

## Property: has_RiskSource

* [pilz_contributions_2022](../Article/PBN__Article_245)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

